Olema Pharmaceuticals: Amendment Increases Aggregate Principal Amount of Loan Facility to up to $100 Mln
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.